Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis
OncoTargets and Therapy2017Vol. Volume 10, pp. 4591–4598
Citations Over TimeTop 10% of 2017 papers
Qingcai Meng, Si Shi, Chen Liang, Dingkong Liang, Wenyan Xu, Shunrong Ji, Bo Zhang, Quanxing Ni, Jin Xu, Xianjun Yu
Abstract
Our meta-analysis indicated that elevated serum CEA level, as a vital supplementary to CA19-9, can play an important role in the clinical diagnosis of pancreatic cancer patients and predict poor prognosis.
Related Papers
- → Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer(2004)61 cited
- [Evaluation of RCAS1 as serum tumor marker for pancreatic cancer].(2009)
- Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer(2004)
- Diagnostic Signigicance of Luminescence Immunity Analysis of CA19-9 and CA242 in Pancreatic Cancer(2003)
- Application of tumor M2 pyruvate kinase and cancer antigen 19-9 in pancreatic cancer(2005)